GBT
Global Blood Therapeutics, Inc.
Delisted
GBT was delisted on the 4th of October, 2022.
196 hedge funds and large institutions have $2.35B invested in Global Blood Therapeutics, Inc. in 2018 Q2 according to their latest regulatory filings, with 44 funds opening new positions, 86 increasing their positions, 48 reducing their positions, and 23 closing their positions.
Holders
196
Holders Change
+20
Holders Change %
+11.36%
% of All Funds
4.49%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.16%
New
44
Increased
86
Reduced
48
Closed
23
Calls
$180M
Puts
$87.2M
Net Calls
+$92.5M
Net Calls Change
+$68.4M
Top Buyers
Top Sellers
1 |
ACA
1
Avoro Capital Advisors
New York
|
$31.7M |
2 |
O
2
OrbiMed
New York
|
$20.2M |
3 |
![]()
3
Fidelity Investments
Boston,
Massachusetts
|
$292M |
4 |
4
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$6.16M |
5 |
RI
5
RTW Investments
New York
|
$0 |